Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKaracin, Cengiz
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorDemirci, Ayse
dc.contributor.authorKeskinkilic, Merve
dc.contributor.authorBaytemur, Naziyet Kose
dc.contributor.authorYilmaz, Funda
dc.contributor.authorSelvi, Oguzhan
dc.contributor.authorErdem, Dilek
dc.contributor.authorAvsar, Esin
dc.contributor.authorPaksoy, Nail
dc.contributor.authorDemir, Necla
dc.contributor.authorGoksu, Sema Sezgin
dc.contributor.authorTurker, Sema
dc.contributor.authorBayram, Ertugrul
dc.contributor.authorCelebi, Abduessamet
dc.contributor.authorYilmaz, Hatice
dc.contributor.authorKuzu, Omer Faruk
dc.contributor.authorKahraman, Seda
dc.contributor.authorGokmen, Ivo
dc.contributor.authorSakin, Abdullah
dc.contributor.authorAlkan, Ali
dc.contributor.authorNayir, Erdinc
dc.contributor.authorUgrakli, Muzaffer
dc.contributor.authorAcar, Omer
dc.contributor.authorErturk, Ismail
dc.contributor.authorDemir, Hacer
dc.contributor.authorAslan, Ferit
dc.contributor.authorSonmez, Ozlem
dc.contributor.authorKorkmaz, Taner
dc.contributor.authorCelayir, Ozde Melisa
dc.contributor.authorKaradag, Ibrahim
dc.contributor.authorKayikcioglu, Erkan
dc.contributor.authorSakalar, Teoman
dc.contributor.authorOktem, Ilker Nihat
dc.contributor.authorEren, Tulay
dc.contributor.authorUrul, Enes
dc.contributor.authorMocan, Eda Eylemer
dc.contributor.authorKalkan, Ziya
dc.contributor.authorYildirim, Nilgun
dc.contributor.authorErgun, Yakup
dc.contributor.authorAkagunduz, Baran
dc.contributor.authorKarakaya, Serdar
dc.contributor.authorKut, Engin
dc.contributor.authorTeker, Fatih
dc.contributor.authorDemirel, Burcin Cakan
dc.contributor.authorKaraboyun, Kubilay
dc.contributor.authorAlmuradova, Elvina
dc.contributor.authorUnal, Olcun Umit
dc.contributor.authorOyman, Abdilkerim
dc.contributor.authorIsik, Deniz
dc.contributor.authorOkutur, Kerem
dc.contributor.authorOztosun, Bugra
dc.contributor.authorGulbagci, Burcu Belen
dc.contributor.authorKalender, Mehmet Emin
dc.contributor.authorSahin, Elif
dc.contributor.authorSeyyar, Mustafa
dc.contributor.authorOzdemir, Ozlem
dc.contributor.authorSelcukbiricik, Fatih
dc.contributor.authorKanitez, Metin
dc.contributor.authorDede, Isa
dc.contributor.authorGumus, Mahmut
dc.contributor.authorGokmen, Erhan
dc.contributor.authorYaren, Arzu
dc.contributor.authorMenekse, Serkan
dc.contributor.authorEbinc, Senar
dc.contributor.authorAksoy, Sercan
dc.contributor.authorImamoglu, Goksen Inanc
dc.contributor.authorAltinbas, Mustafa
dc.contributor.authorCetin, Bulent
dc.contributor.authorUluc, Basak Oyan
dc.contributor.authorEr, Ozlem
dc.contributor.authorKaradurmus, Nuri
dc.contributor.authorErdogan, Atike Pinar
dc.contributor.authorArtac, Mehmet
dc.contributor.authorTanriverdi, Ozgur
dc.contributor.authorCicin, Irfan
dc.contributor.authorSendur, Mehmet Ali Nahit
dc.contributor.authorOktay, Esin
dc.contributor.authorBayoglu, Ibrahim Vedat
dc.contributor.authorPaydas, Semra
dc.contributor.authorAydiner, Adnan
dc.contributor.authorSalim, Derya Kivrak
dc.contributor.authorGeredeli, Caglayan
dc.contributor.authorYavuzsen, Tugba
dc.contributor.authorDogan, Mutlu
dc.contributor.authorHacibekiroglu, Ilhan
dc.date.accessioned2025-10-16T15:15:57Z
dc.date.issued2023
dc.identifier.doi10.1186/s12885-023-10609-8
dc.identifier.otherWOS:000980043700010
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6578
dc.publisherBMC
dc.sourceBMC CANCER
dc.subjectAdvanced breast cancer
dc.subjectCyclin\\-dependent kinase
dc.subjectRibociclib
dc.subjectPalbociclib
dc.subjectEverolimus
dc.subjectFulvestrant
dc.subjectEndocrine treatment
dc.subjectHormonotherapy
dc.titleEfficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
dc.typeArticle

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Thumbnail Image
Ad:
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 46 inhibitor therapy.pdf
Boyut:
1.52 MB
Format:
Adobe Portable Document Format
İndir

Koleksiyonlar

WOS